TD Cowen Raises Danaher (NYSE:DHR) Price Target to $290.00

Danaher (NYSE:DHR) had its target price raised by TD Cowen from $280.00 to $290.00 in a report published on Wednesday, Benzinga reports. TD Cowen currently has a buy rating on the conglomerate’s stock.

DHR has been the topic of a number of other reports. Robert W. Baird increased their price objective on shares of Danaher from $259.00 to $271.00 and gave the stock an outperform rating in a research report on Wednesday. Barclays increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an equal weight rating in a research report on Wednesday. StockNews.com lowered shares of Danaher from a buy rating to a hold rating in a research report on Wednesday, January 31st. HSBC raised shares of Danaher from a hold rating to a buy rating and increased their price objective for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Finally, Citigroup increased their price objective on shares of Danaher from $255.00 to $280.00 and gave the stock a buy rating in a research report on Wednesday, January 31st. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of Moderate Buy and a consensus target price of $270.00.

Danaher Stock Up 0.3 %

Shares of NYSE:DHR opened at $246.45 on Wednesday. The company has a current ratio of 1.85, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. Danaher has a 12 month low of $182.09 and a 12 month high of $259.00. The company has a 50-day moving average price of $248.87 and a 200 day moving average price of $231.08. The company has a market cap of $182.54 billion, a price-to-earnings ratio of 41.77, a PEG ratio of 3.78 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. During the same quarter last year, the firm earned $2.36 EPS. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, equities research analysts predict that Danaher will post 7.65 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Thursday, March 28th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Insider Activity at Danaher

In related news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Teri List sold 3,289 shares of Danaher stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at $4,898,360.32. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Rainer Blair sold 47,175 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the completion of the sale, the chief executive officer now owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The disclosure for this sale can be found here. Insiders have sold a total of 106,565 shares of company stock valued at $26,641,364 over the last ninety days. 11.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently made changes to their positions in the stock. Tsfg LLC grew its position in Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares during the period. Cape Investment Advisory Inc. acquired a new stake in Danaher during the fourth quarter worth about $25,000. BKM Wealth Management LLC acquired a new stake in Danaher during the fourth quarter worth about $27,000. Redmont Wealth Advisors LLC acquired a new stake in Danaher during the first quarter worth about $30,000. Finally, Wetzel Investment Advisors Inc. acquired a new stake in Danaher during the fourth quarter worth about $29,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.